The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruz, P. D.
Right arrow Articles by Bergstresser, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cruz, P. D., Jr
Right arrow Articles by Bergstresser, P. R.

The Journal of Immunology, Vol 144, Issue 7 2486-2492, Copyright © 1990 by American Association of Immunologists


ARTICLES

Langerhans cells that migrate to skin after intravenous infusion regulate the induction of contact hypersensitivity

PD Cruz Jr, RE Tigelaar and PR Bergstresser
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas 75235-9048.

Intravenous infusion of hapten-derivatized epidermal cells (EC) in syngeneic mice leads to two competing signals for contact hypersensitivity (CH), a dominant effector signal attributable to Langerhans cells (LC) and a suppressor signal from Thy-1+ EC. In vitro exposure of LC to low dose ultraviolet B (UVB) radiation before hapten- derivatization and infusion not only results in the abrogation of their effector signal but also causes the down-regulation of subsequent CH responses. To delineate the relevance of i.v. immunization to the study of CH and of LC as the immunologic targets of low dose UVB radiation, we examined the migratory and immunogenic properties of EC after i.v. infusion. Unsorted EC migrated from blood to skin and lymphoid tissues, reaching steady state distributions at 16 h after infusion. No significant differences were observed between the trafficking of EC in syngeneic and allogeneic transfers. LC localized preferentially to skin, whereas Thy-1+ EC trafficked to skin, the thymus, mesenteric lymph nodes, and spleen. The pattern of trafficking of unirradiated and low dose UVB-irradiated LC were identical, suggesting that low dose UVB radiation had little effect on LC migration. Finally, skin graft experiments demonstrated i.v. infused, hapten-derivatized LC that migrate to skin to retain their capacity to induce CH, a property that was converted by in vitro pretreatment with low dose UVB radiation into down-regulation. These findings confirm the relevance and utility of the i.v. immunization model in the study of CH and the influence of low dose UVB on this immune response. Our data also provide a basis for investigating the role of disparate trafficking patterns in generating effector and suppressor signals when hapten-derivatized EC are employed for CH.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Pradhan, H. K. Kim, C. J. Thrash, M. A. Cox, S. K. Mantena, J.-H. Wu, M. Athar, S. K. Katiyar, C. A. Elmets, and L. Timares
A Critical Role for the Proapoptotic Protein Bid in Ultraviolet-Induced Immune Suppression and Cutaneous Apoptosis
J. Immunol., September 1, 2008; 181(5): 3077 - 3088.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. De Creus, K. Van Beneden, T. Taghon, F. Stolz, V. Debacker, J. Plum, and G. Leclercq
Langerhans Cells That Have Matured In Vivo in the Absence of T Cells Are Fully Capable of Inducing a Helper CD4 as Well as a Cytotoxic CD8 Response
J. Immunol., July 15, 2000; 165(2): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Cauli, C. Pitzalis, G. Yanni, M. Awad, and G. S. Panayi
CD1 expression in psoriatic and rheumatoid arthritis
Rheumatology, June 1, 2000; 39(6): 666 - 673.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Strunk, C. Egger, G. Leitner, D. Hanau, and G. Stingl
A Skin Homing Molecule Defines the Langerhans Cell Progenitor in Human Peripheral Blood
J. Exp. Med., March 17, 1997; 185(6): 1131 - 1136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.